152 related articles for article (PubMed ID: 35460354)
21. A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.
Jackson ER; Persson ML; Fish CJ; Findlay IJ; Mueller S; Nazarian J; Hulleman E; van der Lugt J; Duchatel RJ; Dun MD
Neuro Oncol; 2024 May; 26(Supplement_2):S136-S154. PubMed ID: 37589388
[TBL] [Abstract][Full Text] [Related]
22. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.
Findlay IJ; De Iuliis GN; Duchatel RJ; Jackson ER; Vitanza NA; Cain JE; Waszak SM; Dun MD
Oncogene; 2022 Jan; 41(4):461-475. PubMed ID: 34759345
[TBL] [Abstract][Full Text] [Related]
23. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.
Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S
AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840
[TBL] [Abstract][Full Text] [Related]
24. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A
Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431
[TBL] [Abstract][Full Text] [Related]
25. Diffuse midline glioma H3K27M mutation in adult: A case report.
Bhattarai AM; Mainali G; Jha P; Karki P; Adhikari A; Pandit A; Bhattarai AM
Ann Med Surg (Lond); 2022 Apr; 76():103567. PubMed ID: 35495373
[TBL] [Abstract][Full Text] [Related]
26. A rare presentation of a spinal diffuse midline glioma in a child: a case report.
Isfaoun Z; Laasri K; Jidal M; Cherradi N; Melhaoui A; Chat L; Haddad SE; Kababri ME; Khorassani ME; Kili A; Ansari NE; Hessissen L
Pan Afr Med J; 2023; 44():183. PubMed ID: 37484594
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of probe washing after stereotactic needle biopsy as a novel technique for developing cell lines and xenografts of H3 K27-altered diffuse midline gliomas.
Rechberger JS; Zhang L; Ge J; Nesvick CL; Miller KJ; Daniels DJ
J Neurosurg Pediatr; 2023 Oct; 32(4):413-420. PubMed ID: 37486856
[TBL] [Abstract][Full Text] [Related]
28. Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor.
Arunachalam S; Szlachta K; Brady SW; Ma X; Ju B; Shaner B; Mulder HL; Easton J; Raphael BJ; Myers M; Tinkle C; Allen SJ; Orr BA; Wetmore CJ; Baker SJ; Zhang J
Acta Neuropathol Commun; 2022 May; 10(1):80. PubMed ID: 35642016
[TBL] [Abstract][Full Text] [Related]
29. [Diffuse midline glioma].
Saito R
No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
[TBL] [Abstract][Full Text] [Related]
30. Spinal intramedullary H3K27M mutant glioma with vertebral metastasis: a case report.
Handis C; Tanrıkulu B; Danyeli AE; Özek MM
Childs Nerv Syst; 2021 Dec; 37(12):3933-3937. PubMed ID: 33742289
[TBL] [Abstract][Full Text] [Related]
31. The promise of metabolic imaging in diffuse midline glioma.
Lovibond S; Gewirtz AN; Pasquini L; Krebs S; Graham MS
Neoplasia; 2023 May; 39():100896. PubMed ID: 36944297
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
33. A Rare High-Grade Glioma with a Histone H3 K27M Mutation in the Hypothalamus of an Adult Patient.
He P; Chen W; Qiu XX; Xi YB; Guan H; Xia J
World Neurosurg; 2019 Aug; 128():527-531. PubMed ID: 31048046
[TBL] [Abstract][Full Text] [Related]
34. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review.
Mohiuddin S; Maraka S; Usman Baig M; Gupta S; Muzzafar T; Valyi-Nagy T; Lindsay H; Moody K; Razvi S; Paulino A; Slavin K; Gondi V; McCutcheon I; Zaky W; Khatua S
J Clin Neurosci; 2021 Jul; 89():405-411. PubMed ID: 34053821
[TBL] [Abstract][Full Text] [Related]
35. Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures.
Banan R; Akbarian A; Samii M; Samii A; Bertalanffy H; Lehmann U; Hartmann C; Brüning R
PLoS One; 2021; 16(8):e0249647. PubMed ID: 34347774
[TBL] [Abstract][Full Text] [Related]
36. Patient with Diffuse Midline Glioma, H3 K27-altered, Carrying an
Matsunaga K; Fukami S; Nakajima N; Ichimasu N; Kohno M
NMC Case Rep J; 2023; 10():309-314. PubMed ID: 38076395
[TBL] [Abstract][Full Text] [Related]
37. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
[TBL] [Abstract][Full Text] [Related]
38. Pediatric spinal cord diffuse midline glioma with H3 K27M-alteration with leptomeningeal dissemination: a rare case with intracranial hypertension onset and no spinal cord-related symptom.
Liu Y; Sun P; Zhou M; Du J; Zeng G
Childs Nerv Syst; 2023 Jun; 39(6):1663-1666. PubMed ID: 36759369
[TBL] [Abstract][Full Text] [Related]
39. An adult case of diffuse midline glioma with H3 K27M mutation.
Tu JH; Piao YS; Lu DH; Wang LM; Liu L; Bai DY; Han HW; Lin YK; Zhong S
Neuropathology; 2020 Dec; 40(6):627-631. PubMed ID: 32954563
[TBL] [Abstract][Full Text] [Related]
40. Infiltrative gliomas of the thalamus in children: the role of surgery in the era of H3 K27M mutant midline gliomas.
Dorfer C; Czech T; Gojo J; Hosmann A; Peyrl A; Azizi AA; Kasprian G; Dieckmann K; Filbin MG; Haberler C; Roessler K; Slavc I
Acta Neurochir (Wien); 2021 Jul; 163(7):2025-2035. PubMed ID: 33090244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]